Basic principles and technologies for deciphering the genetic map of cancer

World Journal of Surgery

Volumn 33, Issue 4, 2009, Pages 615-629

  Voidonikolas, Georgios ^a   Kreml, Stephanie S ^a   Chen, Changyi ^a   Fisher, William E ^a   Charles Brunicardi, F ^a   Gibbs, Richard A ^a   Gingras, Marie Claude ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SURVIVAL; DNA SEQUENCE; GENE MAPPING; GENOME ANALYSIS; HUMAN; POLYMERASE CHAIN REACTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOCARCINOMA; DNA FRAGMENTATION; GENES, NEOPLASM; GENETIC TECHNIQUES; HUMANS; NEOPLASMS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PANCREATIC NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; SEQUENCE ANALYSIS, DNA;

EID: 62549112118     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-008-9851-y     Document Type: Review

References (153)

1. F Sanger S Nicklen AR Coulson 1997 DNA sequencing with chain-terminating inhibitors Proc Natl Acad Sci USA 74 5463 5467
2. International Consortium completes Human Genome Project [National Human Genome Research Institute web site]. http://www.genome.gov/11006929 14 April 2003
3. AE Guttmacher FS Collins 2003 Welcome to the genomic era N Engl J Med 349 996 998
4. 454 Life Sciences and Baylor College of Medicine Complete Sequencing of DNA Project. [454 Life Sciences website] http://www.454.com/news-events/press- releases.asp?display=detail&id=68 Accessed 31 May 2007
5. DA Wheeler M Srinivasan M Egholm 2008 The complete genome of an individual by massively parallel DNA sequencing Nature 452 872 876
6. BP Kopnin 2000 Targets of oncogenes and tumor suppressors: key for understanding basic mechanisms of carcinogenesis Biochemistry (Mosc) 65 2 27
7. CM Croce 2008 Oncogenes and cancer N Engl J Med 358 502 511
8. SJ Elledge GJ Hannon 2005 An open letter to cancer researchers Science 310 439 441
9. HH Heng 2007 Cancer genome sequencing: the challenges ahead Bioessays 29 783 794
10. H Varmus 2006 The new era in cancer research Science 312 1162 1165
11. T Sjöblom S Jones LD Wood 2006 The consensus coding sequences of human breast and colorectal cancers Science 314 268 274
12. Cancer Sequencing Projects (CSPs) [National Human Genome Research Institute web site]. http://www.genome.gov/19517442
13. BA Weir MS Woo G Getz 2007 Characterizing the cancer genome in lung adenocarcinoma Nature 450 893 898
14. FS Collins AD Barker 2007 Mapping the cancer genome. Pinpointing the genes involved in cancer will help chart a new course across the complex landscape of human malignancies Sci Am 296 50 57
15. BJ Druker M Talpaz DJ Resta 2001 Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia N Engl J Med 344 1031 1037
16. DJ Slamon B Leyland-Jones S Shak 2001 Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N Engl J Med 344 783 792
17. MC Heinrich CL Corless GD Demetri 2003 Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor J Clin Oncol 21 4342 4349
18. JG Paez PA Jänne JC Lee 2004 EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 1497 1500
19. W Pao VA Miller KA Politi 2005 Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain LoS Med 2 e73
20. S Kobayashi TJ Boggon T Dayaram 2005 EGFR mutation and resistance of non-small-cell lung cancer to gefitinib N Engl J Med 352 786 792
21. AL McGuire RA Gibbs 2006 Genetics. No longer de-identified Science 312 370 371
22. AL McGuire RA Gibbs 2006 Currents in contemporary ethics: meeting the growing demands of genetic research J Law Med Ethics 34 809 812
23. AL McGuire T Caulfield MK Cho 2007 Research ethics and the challenge of whole genome sequencing Nat Rev Gen 9 152 156
24. G Renegar CJ Webster S Stuerzebecker 2006 Returning genetic research results to individuals: points to consider Bioethics 20 24 36
25. BM Knoppers Y Joly J Simard 2006 The emergence of an ethical duty to disclose genetic research results: international perspectives Eur J Human Gen 14 1170 1178
26. S MacNeil C Fernandez 2006 Informing research participants of research results: analysis of Canadian university based research ethics board policies J Med Ethics 32 49 54
27. IS Kohane KD Mandi PL Taylor 2007 Reestablishing the researcher-patient compact Science 316 836 837
28. AF Rubin P Green 2007 Comment on "the consensus coding sequences of human breast and colorectal cancers" Science 317 1500
29. G Getz H Höfling JP Mesirov 2007 Comment on "the consensus coding sequences of human breast and colorectal cancers" Science 317 1500
30. D Mahadevan DD Von Hoff 2007 Tumor-stroma interactions in pancreatic ductal adenocarcinoma Mol Cancer Ther 6 1186 1197
31. E Check 2007 Cancer atlas maps out sample worries Nature 447 1036 1037
32. C Compton 2007 Getting to personalized cancer medicine: taking out the garbage Cancer 110 1641 1643
33. SM Tu SH Lin CJ Logothetis 2002 Stem-cell origin of metastasis and heterogeneity in solid tumours Lancet Oncol 3 508 513
34. MF Woodruff 1983 Cellular heterogeneity in tumours Br J Cancer 47 589 594
35. JH Kim T Tuziak L Hu 2005 Alterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathways Lab Invest 85 532 549
36. The Cancer Genome Atlas Biospecimen Selection Process. The Cancer Genome Atlas website. http://cancergenome.nih.gov/components/hcbcr-process.asp
37. GI Murray 2007 An overview of laser microdissection technologies Acta Histochem 109 171 176
38. SR Mager MH Oomen MM Morente 2007 Standard operating procedure for the collection of fresh frozen tissue samples Eur J Cancer 43 828 834
39. MI Gallegos Ruiz K Floor F Rijmen 2007 EGFR and K-ras mutation analysis in non-small cell lung cancer: comparison of paraffin embedded versus frozen specimens Cell Oncol 29 257 264
40. I Ferrer J Armstrong S Capellari 2007 Effects of formalin fixation, paraffin embedding, and time of storage on DNA preservation in brain tissue: a BrainNet Europe study Brain Pathol 17 297 303
41. CN Andreassen FB Sørensen J Overgaard 2004 Optimisation and validation of methods to assess single nucleotide polymorphisms (SNPs) in archival histological material Radiother Oncol 72 351 356
42. PM Lizardi X Huang Z Zhu 1998 Mutation detection and single-molecule counting using isothermal rolling-circle amplification Nat Genet 19 225 232
43. FB Dean JR Nelson TL Giesler 2001 Rapid amplification of plasmid and phage DNA using Phi 29 DNA polymerase and multiply-primed rolling circle amplification Genome Res 11 1095 1099
44. R Pinard A de Winter GJ Sarkis 2006 Assessment of whole genome amplification-induced bias through high-throughput, massively parallel whole genome sequencing BMC Genomics 7 216
45. Genomic DNA Preparation from RNAlater™ Preserved Tissues [Ambion website]. (2008) http://www.ambion.com/techlib/misc/genomicDNA-rnalater.html
46. Catalogue of somatic mutations in cancer [Sanger Institute COSMIC website] http://www.sanger.ac.uk/genetics/CGP/cosmic/
47. Pancreatic Cancer Gene Database [PCGD website] http://www.bioinformatics. org/pcgdb/
48. B Vogelstein KW Kinzler 2004 Cancer genes and the pathways they control Nat Med 10 789 799
49. PA Futreal L Coin M Marshall 2004 A census of human cancer genes Nat Rev Cancer 4 177 183
50. TA Brentnall 2005 Management strategies for patients with hereditary pancreatic cancer Curr Treat Options Oncol 6 437 445
51. DH Berger WE Fisher 2002
52. CD Logsdon DM Simeone C Binkley 2003 Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer Cancer Res 63 2649 2657
53. M Buchholz HA Kestler A Bauer 2005 Specialized DNA arrays for the differentiation of pancreatic tumors Clin Cancer Res 11 8048 8054
54. ME Higgins M Claremont JE Major 2007 CancerGenes: a gene selection resource for cancer genome projects Nucleic Acids Res 35 D721 D726
55. Resequencing Resource http://cbio.mskcc.org/cancergenes/index.php
56. TJ Albert MN Molla DM Muzny 2007 Direct selection of human genomic loci by microarray hybridization Nat Methods 4 903 905
57. E Hodges Z Xuan V Balija 2007 Genome-wide in situ exon capture for selective resequencing Nat Genet 39 1522 1527
58. Repeat Masker (2003) [computer program] Institute for Systems Biology http://www.repeatmasker.org/
59. Single Nucleotide Polymorphism database [NCBI website]. http://www.ncbi.nlm.nih.gov/projects/SNP/ Accessed 17 Jan 2008
60. Primer3. Howard Hughes Medical Institute [Primer3 website]. http://frodo.wi.mit.edu/ Accessed 7 Feb 2007
61. UCSC In-Silico PCR [UCSC Genome Bioinformatics website]. http://genome.ucsc.edu/cgi-bin/hgPcr?command=start
62. P Parameswaran R Jalili L Tao 2007 A pyrosequencing-tailored nucleotide barcode design unveils opportunities for large-scale sample multiplexing Nucleic Acids Res 35 e130
63. M Ronaghi M Uhlén P Nyrén 1998 A sequencing method based on real-time pyrophosphate Science 28 363 365
64. M Margulies M Egholm WE Altman 2005 Genome sequencing in microfabricated high-density picolitre reactors Nature 37 376 380
65. RK Thomas E Nickerson JF Simons 2006 Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing Nat Med 12 852 855
66. Solexa Ltd (2004) Pharmacogenomics 5:433-438
67. ST Bennett C Barnes A Cox 2005 Toward the 1, 000 dollars human genome Pharmacogenomics 6 373 382
68. Solexa sequencing Technology Illumina website. http://www.illumina.com/ pages.ilmn?ID=203
69. A Dutt R Beroukhim 2007 Single nucleotide polymorphism array analysis of cancer Curr Opin Oncol 19 43 49
70. ES Calhoun T Hucl E Gallmeier 2006 Identifying allelic loss and homozygous deletions in pancreatic cancer without matched normals using high-density single-nucleotide polymorphism arrays Cancer Res 66 7920 7928
71. T Harada C Chelala V Bhakta 2008 Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays Oncogene 27 1951 1960
72. Cargill M, Altshuler D, Ireland J et al (1999) Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 22:231-238 (erratum Nat Genet 23:373)
73. L Kruglyak DA Nickerson 2001 Variation is the spice of life Nat Genet 27 234 236
74. DA Hinds LL Stuve GB Nilsen 2005 Whole-genome patterns of common DNA variation in three human populations Science 307 1072 1079
75. T Bernig SJ Chanock 2006 Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer Expert Rev Mol Diagn 6 319 331
76. J Abraham HM Earl PD Pharoah C Caldas 2006 Pharmacogenetics of cancer chemotherapy Biochim Biophys Acta 1766 168 183
77. T Bernig SJ Chanock 2006 Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer Expert Rev Mol Diagn 6 319 331
78. CM West RM Elliott NG Burnet 2007 The genomics revolution and radiotherapy Clin Oncol (R Coll Radiol) 19 470 480
79. EN Imyanitov AV Togo KP Hanson 2004 Searching for cancer-associated gene polymorphisms: promises and obstacles Cancer Lett 204 3 14
80. Bodmer WF, Bailey CJ, Bodmer J et al (1987) Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 19;32:614-616
81. LA Cannon-Albright DE Goldgar LJ Meyer 1992 Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22 Science 258 1148 1152
82. R Wooster SL Neuhausen J Mangion 1994 Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13 Science 265 2088 2090
83. P Armitage R Doll 1954 The age distribution of cancer and a multi-stage theory of carcinogenesis Br J Cancer 8 1 12
84. MJ Renan 1993 How many mutations are required for tumorigenesis? Implications from human cancer data Mol Carcinog 7 139 146
85. RA Beckman LA Loeb 2005 Genetic instability in cancer: theory and experiment Semin Cancer Biol 15 423 435
86. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell 100 57 70
87. RN Venkatesan JH Bielas LA Loeb 2006 Generation of mutator mutants during carcinogenesis DNA Repair 5 294 302
88. C Kimchi-Sarfaty JM Oh IW Kim 2007 A "silent" polymorphism in the MDR1 gene changes substrate specificity Science 315 525 528
89. D McClintock D Ratner M Lokuge 2007 The mutant form of Lamin A that causes Hutchinson-Gilford Progeria is a biomarker of cellular aging in human skin PLoS ONE 2 e1269
90. B Conne A Stutz JD Vassalli 2000 The 3 untranslated region of messenger RNA: a molecular "hotspot" for pathology? Nat Med 6 637 641
91. J Duan MS Wainwright JM Comeron 2003 Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor Hum Mol Genet 12 205 216
92. B Hoogendoorn SL Coleman CA Guy 2003 Functional analysis of human promoter polymorphisms Hum Mol Genet 12 2249 2254
93. F Pagani FE Baralle 2004 Genomic variants in exons and introns: identifying the splicing spoilers Nat Rev Genet 5 389 396
94. C Greenman P Stephens R Smith 2007 Patterns of somatic mutation in human cancer genomes Nature 446 153 158
95. KJ Livak 1999 Allelic discrimination using fluorogenic probes and the 5 nuclease assay Genet Anal 14 143 149
96. P Hardenbol F Yu J Belmont 2005 Highly multiplexed molecular inversion probe genotyping: over 10,000 targeted SNPs genotyped in a single tube assay Genome Res 15 269 275
97. PA Bell S Chaturvedi CA Gelfand 2002 SNPstream UHT: ultra-high throughput SNP genotyping for pharmacogenomics and drug discovery Biotechniques 74 76 77
98. Iplex Gold Review [Sequenom website] http://www.sequenom.com/Genetic- Analysis/Applications/iPLEX-Genotyping/iPLEX-Overview.aspx
99. JB Fan A Oliphant R Shen 2003 Highly parallel SNP genotyping Cold Spring Harb Symp Quant Biol 68 69 78
100. Genechip Arrays [Affymetrix website]. http://www.affymetrix.com/products/ arrays/index.affx
101. KL Gunderson FJ Steemers G Lee 2005 A genome-wide scalable SNP genotyping assay using microarray technology Nat Genet 37 549 554
102. MS van der Heijden SE Kern 2005
103. CA Moskaluk RH Hruban SE Kern 1997 p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma Cancer Res 57 2140 2143
104. RH Hruban RE Wilentz SE Kern 2000 Genetic progression in the pancreatic ducts Am J Pathol 156 1821 1825
105. RH Hruban CJ Yeo SE Kem 2002
106. SL MacLeod P Chowdhury 2006 The genetics of nicotine dependence: relationship to pancreatic cancer World J Gastroenterol 12 7433 7439
107. M Porta N Malats M Jariod 1999 Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group Lancet 354 2125 2129
108. J Alguacil M Porta T Kauppinen 2003 KRAS II Study Group. Occupational exposure to dyes, metals, polycyclic aromatic hydrocarbons and other agents and K-ras activation in human exocrine pancreatic cancer Int J Cancer 107 635 641
109. SC Larsson E Giovannucci A Wolk 2006 Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis Gastroenterology 131 1271 1283
110. L Jiao ML Bondy MM Hassan 2007 Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancer Cancer 109 840 848
111. J Chen D Li C Wei 2007 Aurora-A and p16 polymorphisms contribute to an earlier age at diagnosis of pancreatic cancer in Caucasians Clin Cancer Res 13 3100 3104
112. L Jiao MM Hassan ML Bondy 2007 The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk Cancer Lett 245 61 68
113. L Jiao MM Hassan ML Bondy 2007 XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer Am J Gastroenterol 16 2379 2386
114. L Jiao ML Bondy MM Hassan 2006 Selected polymorphisms of DNA repair genes and risk of pancreatic cancer Cancer Detect Prev 30 284 291
115. CD Rogers FJ Couch K Brune 2004 Genetics of the FANCA gene in familial pancreatic cancer J Med Genet 41 e126
116. KL Pogue-Geile R Chen MP Bronner T Crnogorac-Jurcevic 2006 Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism PLoS Med 3 e516
117. P Berthelemy M Bouisson J Escourrou 1995 Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer Ann Intern Med 123 188 191
118. T van Heek AE Rader JA Offerhaus 2002 K-ras, p53, and DPC4 (MAD4) alterations in fine-needle aspirates of the pancreas: a molecular panel correlates with and supplements cytologic diagnosis Am J Clin Pathol 117 755 765
119. K Takahashi K Yamao K Okubo 2005 Differential diagnosis of pancreatic cancer and focal pancreatitis by using EUS-guided FNA Gastrointest Endosc 61 76 79
120. T Itoi K Takei A Sofuni 2005 Immunohistochemical analysis of p53 and MIB-1 in tissue specimens obtained from endoscopic ultrasonography-guided fine needle aspiration biopsy for the diagnosis of solid pancreatic masses Oncol Rep 13 229 234
121. M Lohr P Muller J Mora 2001 p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis Gastrointest Endosc 53 734 743
122. V Pugliese N Pujic S Saccomanno 2001 Pancreatic intraductal sampling during ERCP in patients with chronic pancreatitis and pancreatic cancer: cytologic studies and K-ras-2 codon 12 molecular analysis in 47 cases Gastrointest Endosc 54 595 599
123. DH Berger H Chang M Wood 1999 Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status Cancer 85 326 332
124. C Caldas SA Hahn LT da Costa 1994 Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma Nat Genet 8 27 32
125. H Kalthoff W Schmiegel C Roeder 2003 p53 and K-ras alterations in pancreatic epithelial cell lesions Oncogene 8 289 298
126. CA Moskaluk RH Hruban SE Kern 1997 p16 and K-ras mutations in the intraductal precursors of human pancreatic adenocarcinoma Cancer Res 57 2140 2143
127. M Tada M Omata S Kawai 1993 Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma Cancer Res 53 2472 2474
128. K Ohtsubo H Watanabe Y Yamaguchi 2003 Abnormalities of tumor suppressor gene p16 in pancreatic carcinoma: immunohistochemical and genetic findings compared with clinicopathological parameters J Gastroenterol 38 663 671
129. M Dong G Ma W Tu 2003 Clinicopathological significance of p53 and mdm2 protein expression in human pancreatic cancer World J Gastroenterol 11 2162 2165
130. M Yokoyama Y Yamanaka H Friess 1994 p53 expression in human pancreatic cancer correlates with enhanced biological aggressiveness Anticancer Res 14 2477 2483
131. P Ghaneh W Greenhalf M Humphreys 2001 Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo Gene Ther 8 199 208
132. M Tascilar HG Skinner C Rosty 2001 The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma Clin Cancer Res 7 4115 4121
133. D Li Y Li L Jiao 2007 Effects of base excision repair gene polymorphisms on pancreatic cancer survival Int J Cancer 120 1748 1754
134. D Li H Liu L Jiao 2006 Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival Cancer Res 66 3323 3330
135. D Li M Frazier DB Evans 2006 Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer J Clin Oncol 24 1720 1728
136. J Lee KT Jang CS Ki 2007 Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma Cancer 109 1561 1569
137. H Ueno K Kiyosawa N Kaniwa 2007 Pharmacogenomics of gemcitabine: can genetic studies lead to tailor-made therapy? Br J 97 145 151
138. SN Myers RK Goyal JD Roy 2006 Functional single nucleotide polymorphism haplotypes in the human equilibrative nucleoside transporter 1 Pharmacogenet Genomics 16 315 320
139. JR Kroep WJ Loves CL van der Wilt 2002 Pretreatment deoxycytidine kinase levels predict in vivo gemcitabine sensitivity Mol Cancer Ther 1 371 376
140. E Gross K Seck S Neubauer 2003 High-throughput genotyping by DHPLC of the dihydropyrimidine dehydrogenase gene implicated in (fluoro)pyrimidine catabolism Int J Oncol 22 325 332
141. ST Pullarkat J Stoehlmacher V Ghaderi 2001 Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy Pharmacogenomics J 1 65 70
142. J Stoehlmacher V Ghaderi S Iobal 2001 A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer Anticancer Res 21 3075 3079
143. JS Ryu YC Hong HS Han 2004 Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy Lung Cancer 44 311 316
144. DJ Park J Stoehlmacher W Zhang 2001 A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer Cancer Res 61 8654 8658
145. MS van der Heijden JR Brody DA Dezentje 2005 In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor Clin Cancer Res 11 7508 7515
146. SM Sebti AA Adjei 2004 Farnesyltransferase inhibitors Semin Oncol 31 28 39
147. Van Cutsem E, van de Velde H, Karasek P et al (2004) Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer. J Clin Oncol 22:1430-1438
148. GI-4000 for mutated-Ras mediated cancers [GlobeImmune website]. http://www.globeimmune.com/index.php
149. SSW Ng MS Tsao S Chow 2000 Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells Cancer Res 60 5451 5455
150. MJ Moore D Goldstein J Hamm 2007 National Cancer Institute of Canada Clinical Trials Group. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group J Clin Oncol 25 1960 1966
151. CW Tzeng A Frolov N Frolova 2007 Pancreatic cancer epidermal growth factor receptor (EGFR) intron 1 polymorphism influences postoperative patient survival and in vitro erlotinib response Ann Surg Oncol 14 2150 2158
152. RE Brand MM Lerch WS Rubinstein 2007 Advances in counselling and surveillance of patients at risk for pancreatic cancer Gut 56 1460 1469
153. MI Canto 2007 Strategies for screening for pancreatic adenocarcinoma in high-risk patients Semin Oncol 34 295 302